13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 9 managers

Reported value

$247.7M

Holders

9

+0 new · −0 exited

Holders’ est. mark

$7.14M

Price effect on 4 books still in the name

Largest holder

$206M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC2.73M$206MHeld
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main14.2M$36.6M$6.29MAdded$6.33M
Swiss Life Asset Management Ltd36.1K$3.75M$686.3KAdded$569.6K
Leonteq Securities AG4.89K$505.8K$91.5KCut−$115.6K
Marex Group plc4.34K$449KHeld
Burton Enright Welch4.08K$422K$76.3KCut−$170K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.